← Back to Clinical Trials
Recruiting NCT02296307

NCT02296307 DOvEE - Diagnosing Ovarian & Endometrial Cancer Early

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02296307
Status Recruiting
Phase
Sponsor McGill University
Condition Ovarian Neoplasms
Study Type OBSERVATIONAL
Enrollment 13,600 participants
Start Date 2012-01
Primary Completion 2025-01

Trial Parameters

Condition Ovarian Neoplasms
Sponsor McGill University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 13,600
Sex FEMALE
Min Age 45 Years
Max Age N/A
Start Date 2012-01
Completion 2025-01
Interventions
Blood test: CA-125 biomarkerSecond Test: Transvaginal UltrasoundFollow-up phone call

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study hopes to improve early detection of ovarian and endometrial cancers. It will determine if women with bloating, abdominal distension, abdominal/pelvic pain, increased urinary frequency and/or early satiety, benefit from earlier surgery after screening by CA-125 ovarian cancer biomarker and transvaginal ultrasound.

Eligibility Criteria

Inclusion Criteria: 1. Sign an approved informed consent form (ICF). 2. Be ≥ 45 years of age. 3. Have at least one symptom outlined in below for a period of ≥2 weeks but ≤ 1 year: * Feeling full after eating only a few bites, loss of appetite * Diarrhea, constipation, bowel or rectum feels full, change in bowel habits, constant urge to have a bowel movement, painful or burning bowel movements, rectal pain, painful defecation * Bloating, distension of abdomen, clothes around the waist feel too tight, feel an abdominal mass * Weight loss not because of dieting * Nausea, vomiting, heartburn, gas, burping, indigestion * Increased urinary frequency, need to urinate urgently, pressure on the bladder, leaking urine, burning sensation when urinating, need to urinate but unable to do so, unable to empty bladder completely, feeling full after urinating * Vaginal discharge, bleeding, spotting, deep pain on intercourse * Discomfort or pain in abdomen, or pelvic region, or lower back 4. Subjects mu

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology